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SUMMARY
The dissection of apicomplexan biology has been highly influenced by the genetic tools available for manipulation of
parasite DNA. Here, we describe different techniques available for the generation of conditional mutants. Comparison of
the advantages and disadvantages of the three most commonly used regulation systems: the tetracycline inducible system,
the regulation of protein stability and site-specific recombination are discussed. Using some previously described examples
we explore some of the pitfalls involved in gene-function analysis using these systems that can lead to wrong or over-
interpretation of phenotypes. We will also mention different options to standardize the application of these techniques for
the characterization of gene function in high-throughput.
Key words: apicomplexan parasites, gold-standard genetic tools, conditional mutants, tetracycline inducible system,
protein destabilization, DiCre.
INTRODUCTION
TheApicomplexa phylum consists ofmore than 5000
species, most of which are obligate intracellular para-
sites and include important human and veterinary
pathogens, such as Plasmodium spp., Toxoplasma
gondii, Cryptosporidium spp., Eimeria tenella and
Neospora caninum. The defining feature common to
all apicomplexans is the presence of the apical com-
plex, from which secretory organelles (e.g. rhoptries,
micronemes) release their contents during cell in-
vasion (Nichols et al. 1983; Carruthers et al. 1999).
To date, no effective vaccines or treatments are
available against the disease-causing apicomplexans
such as T. gondii (Zhang et al. 2013) or N. caninum
(Reichel and Ellis, 2009). Moreover, the develop-
ment of drug resistance remains a serious threat
against the control of malaria (Chong et al. 2013). In
order to drive the discovery of targets for parasite
disease control forward we need to invest in the
development of new molecular strategies to achieve a
better understanding of basic parasite biology.
Several key technologies have emerged that have
allowed the molecular dissection of functions in
important pathogens (Meissner et al. 2007; Pino,
2013). In addition, publication of several apicomplex-
anparasite genomes in theEuPathDBdatabase (www.
eupathdb.org) allows for fast and robust in silico
identification of promising candidate genes through
comparative genome studies (Aurrecoechea et al.
2010). However, not all apicomplexan parasites
are amenable to genetic manipulation due to difficul-
ties in continuous in vitro cultivation, transfection or
isolation of intracellular developmental stages in
sufficient numbers for downstream molecular ap-
plications (Oberstaller et al. 2013). The development
of several reverse genetic tools in T. gondii has re-
inforced its role as a major model system for studying
other apicomplexan parasites and also for conserved
biological processes in less related organisms
(Meissner et al. 2007). Several techniques based on
the homologous recombination of exogenous DNA
have allowed the generation of knockouts after the
removal of the gene of interest (GOI) (reviewed in
Jakot et al. 2013). Moreover, the efficiency of these
approaches has been improved after the generation of
strains deficient in the non-homologous end joining
repair (NHEJ) pathway (Fox et al. 2009; Huynh and
Carruthers 2009) allowing for repeated and efficient
stable transfection in T. gondii (Sheiner et al. 2011;
Andenmatten et al. 2013; Pieperhoff et al. 2013).
In a haploid organism such as T. gondii, the char-
acterization of essential genes requires the employ-
ment of conditional systems that allow a tight
and reliable regulation of gene activity. Current
approaches for down-regulation of genes in other
organisms, such as interference RNA (RNAi) and
double-strand RNA (dsRNA), have been unsuccess-
ful to date (Kolev et al. 2011). Here we discuss the
advantages and disadvantages of the three most
commonly used conditional regulation systems in
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T. gondii: Tet-inducible transcription (Meissner et al.
2001, 2002), rapid protein destabilization (Herm-
Gotz et al. 2007) and conditional site-specific recom-
bination (Andenmatten et al. 2013). With future
phenome project development in mind, we will
discuss which of these systems allow a high-through-
put approach in combination with gene-editing or
Recombineering technologies.
WHAT IS THE OPTIMAL SYSTEM TO GENERATE
CONDITIONAL MUTANTS?
Conditional regulation systems allow the functional
analysis of essential genes for the biology of an or-
ganism.When studying anessential gene, oneneeds to
be aware of the intrinsic advantages anddisadvantages
of each regulation system. In our opinion, the ideal
conditional knockout system should have five proper-
ties: (i) rapid regulation of theGOI; (ii) reversible and
tuneable regulation of gene activity; (iii) efficient
regulation of gene function without any residual
activity; (iv) generation of a conditional, clonal
knockout strain that can be easily analysed; and
(v) prior to induction, the introduced modifications
should not interfere with the GOI’s function.
Unfortunately such a conditional regulation sys-
tem does not yet exist for T. gondii and other model
systems and therefore the advantages and disadvan-
tages of each conditional system need to be carefully
considered before a lengthy experimental approach is
started (Table 1).
Tetracycline inducible system
The tetracycline resistance operon is recognized in
genetic engineering as a useful tool for the manipu-
lation of transcription regulation in eukaryotic cells.
Two versions of tetracycline (Tet)-dependent gene
regulation find widespread application, allowing
either conditional repression or activation of tran-
scription of the GOI. The repression system mimics
the bacterial system, by placing Tet operator (TetO)
sequences close to the transcriptional start site of a
GOI, leading to a block in transcription initiation
upon binding of the Tet repressor (TetR). Addition
of tetracycline, or tetracycline derivatives such as
doxycycline, abolishes DNA-binding and conse-
quently allows transcription. This regulation system
has been successfully employed in a variety of
eukaryotes (Lovett et al. 2000), including protozoan
parasites (Wirtz and Clayton, 1995; Hamann et al.
1997; Ramakrishnan et al. 1997; Wirtz et al. 1999).
An analogous system was developed in T. gondii, but
this was not sufficient for the generation of con-
ditional mutants (Meissner et al. 2001). Although
the expression of a bulkier version of TetR led to
an increased regulation efficiency (van Poppel et al.
2006) this system in general suffers from a high
residual activity in the repressed state. Furthermore,
the necessity of keeping conditional mutants in the
presence of the inducer anhydrotetracycline (ATc),
less toxic forT. gondii, increases the risk of revertants.
In contrast, the Tet-transactivator system (Gossen
and Bujard, 1992) is based on a tetracycline-
responsive promoter (TRE), where TetO sequences
are placed upstream of a minimal promoter. Fur-
thermore, the fusion of TetR to a virion protein 16
(VP16) transactivating domain of the Herpes simplex
virus generated an efficient tetracycline-dependent
transactivator (tTA). Consequently, binding of
tTA to the TRE activates transcription of the GOI,
whereas addition of ATc abolishes binding of tTA
to TetO resulting in inactivation of transcription.
While this system found widespread employment
in diverse eukaryotes, a direct adaptation in apicom-
plexan parasites was not possible due to the inability
of tTA to activate transcription from TRE (Meissner
et al. 2001).
Table 1. Summary of the technologies described in this review
Conditional recombination (DiCre) Tet system ddFKBP system
Regulation
efficiency
Up to 99% knockouts in populationa 100% knockdowns with
10–50-fold regulationb
100% knockdowns with
1–10-fold regulationc
Advantages No reversion Reversible Rapid regulation
No background expression
GOI under control of
endogenous promoter
Inducer (ATc) can be used
in vivo
GOI under control of
endogenous promoter
Single vector approach for
endogenous tagging and knockdown
Disadvantage Not reversible
No clonal population
Reversion and background
expression
Reversion and background
expression
Not controlled under
endogenous promoter
Only proteins accessible to the
proteasome
Suggested
usage
Knockouts and over-expression/
trans-dominant mutants
Reversible knockdowns Over-expression/trans-dominant
mutants
a Andenmatten et al. (2013).
b Meissner et al. (2002).
c Herm-Gotz et al. (2007).
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To overcome the lack of activity of the transcrip-
tion activation domain, a screen was performed in
T. gondii to identify Toxoplasma sequences that sup-
port tTA transcription (Meissner et al. 2002). The
transactivator isolated, TATi-1 (trans-activator trap
identified), showed tightly inducible regulation. This
artificial transactivator has also been shown to be ac-
tive in Plasmodium falciparum (Meissner et al. 2005).
To date, this system has been used to functionally
analyse numerous genes inT. gondii (Limenitakis and
Soldati-Favre, 2011).
A parasite strain expressing this transactivator (RH
ΔKu80 TATi-1) was created to aid the targeting of
endogenous gene sequences via homologous recom-
bination (Sheiner et al. 2011). Here, replacement
of the endogenous GOI promoter by homologous
recombination with a Tet-inducible promoter is
sufficient to control the transcription of the GOI.
Recently more powerful transactivators, TRADs
(trans-activating domains), derived from ApiAP2
transcription factors have been established. TRAD4
has been shown to be suitable for the study of genes
essential for the erythrocytic stages of Plasmodium
berghei development (Pino et al. 2012).
While the Tet-transactivator system will remain
one of the workhorses for the functional characteriza-
tion of essential genes there are some major pitfalls.
With this technique gene expression can be reversibly
regulated, although a tuneable regulation is not possi-
ble. This technology allows generation of clonal
knockdown strains that can be easily analysed.
However, despite the efficiency in gene regulation
observed it usually takes a long time until protein
levels of the GOI are undetectable depending on the
relative protein stability. Moreover, every minimal
promoter tested thus far shows some residual activity
(Meissner et al. unpublished results), thus it does not
allow complete down-regulation of gene function.
In addition, since it does not allow expression of the
GOI from its endogenous promoter, certain genes
will be expressed at the wrong time and at different
expression levels in the ‘ON’ state.
Rapid regulation of protein stability
In order to obtain de-stabilization domains based on
the rapamycin-binding protein FKBP-12 (ddFKBP)
random mutations were introduced in this protein.
The mutated proteins were screened for Shield-1
(Shld-1)-dependent regulation. Addition of Shld-1,
an analogue of rapamycin, resulted in rapid stab-
ilization and removal of this ligand in rapid destabi-
lization of ddFKBP (Banaszynski et al. 2006).
Importantly, N- or C-terminal fusion of ddFKBP
with a protein of interest allows efficient, rapid and
reversible degradation.
This system has been successfully adapted in
apicomplexan parasites (Armstrong and Goldberg,
2007; Herm-Gotz et al. 2007; de Azevedo et al. 2012)
and has been used successfully in P. falciparum to
generate knockdown mutants (Russo et al. 2009;
Dvorin et al. 2010).
The rapid response kinetic of the ddFKBP-system
is of particular advantage when rapid processes are to
be analysed, such as components of trafficking sys-
tems or signalling cascades. A disadvantage of this
technology is that proteins residing within organelles
typically cannot be regulated using this destabiliza-
tion domain since the fused protein needs to be ac-
cessible to the proteasome which resides in the
cytosol. It has been reported that administration of
Shld-1 can cause delayed parasite growth thus it is an
important requirement to include appropriate con-
trols for phenotype interpretation (de Azevedo et al.
2012).
Other destabilization domains have been devel-
oped, such as DHFR-based systems (DDD)
(Iwamoto et al. 2010). This system used Escherichia
coli DHFR as a candidate protein to engineer a
second destabilizing domain with improved proper-
ties. After addition of trimethoprim (TMP), EcDDD
showed faster degradation kinetics. Another im-
portant advantage of using the DDD system is that
TMP ligand is commercially available, is relatively
cheap, and possesses good pharmacological charac-
teristics. This system has been demonstrated in
P. falciparum combined with GFP and HA se-
quences to study the role of Rpn6 asparagine repeat
(Muralidharan et al. 2011).
While in principle protein degradation systems
should allow a rapid generation of knockdown mu-
tants in T. gondii by simply tagging the endogenous
GOI with this domain, our experience with ddFKBP
is rather discouraging, since after successful tagging
of the protein of interest no efficient destabilization
could be observed (Meissner et al. unpublished
results). One obstacle might be that during prolonged
selection of parasite mutants in the presence of
Shld-1 reversions occur, leading to inefficient regu-
lation. Alternatively, it is possible that proteins that
are associated in a multi-protein complex might be
stabilized due to their interaction with other com-
ponents of the complex. This was the case for com-
ponents of the MyoA-motor complex (unpublished).
In contrast, the system is particularly well suited for
the regulated expression of dominant negative mu-
tants or for the generation of over-expression pheno-
types (Herm-Gotz et al. 2007; Agop-Nersesian et al.
2009, 2010; Breinich et al. 2009; van Dooren et al.
2009; Daher et al. 2010; Kremer et al. 2013).
An exciting possibility for future forward genetic
screens could be the use of a cDNA library fused to
ddFKBP to screen for over-expression phenotypes as
recently demonstrated on a small scale for apicom-
plexan Rab-GTPases (Kremer et al. 2013).
Despite the advantages of the ddFKBP-system,
major obstacles remain to be solved in order to
generate conditional knockdown mutants at a larger
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scale. One advantage of this system is the possibility
of reversible and tuneable regulation. Moreover, it
allows the generation of clonal knockdown strains
that can be easily analysed. On the contrary, whereas
the regulation can be efficient and rapid, the success
rate for the regulation of endogenous proteins ap-
pears to be low. Inefficient regulation is frequently
observed, even for over-expression and dominant
negative mutants.
Site-specific recombinase systems (SSR)
Site-specific recombinase systems offer attractive
possibilities for genetic manipulations and have
found widespread use in different model systems
to specifically remove DNA-sequences flanked by
recombinase-specific recognition sites (Garcia-Otin
and Guillou, 2006). A major bottleneck for the use of
SSR in single-celled organisms is the necessity to
tightly regulate the excision event. Different methods
have been developed to control the expression of re-
combinases including heat-shock promoters (Combe
et al. 2009), mutations in the loxP or FRT sites to
block the reverse reaction (Arakawa et al. 2001), Tet-
inducible systems (Plageman and Lang, 2012) and
hormone-binding domain systems (Metzger et al.
1995; Brecht et al. 1999).While inP. berghei temporal
control of the excision event is achieved by the stage-
specific expression of Flp-recombinase in deletion
clones (Carvalho et al. 2004; Lacroix et al. 2011), a
ligand-controlled approach has been particularly
successful in T. gondii (Andenmatten et al. 2013)
andP. falciparum (Collins et al. 2013). This approach
is known as the DiCre system, in which the Cre
recombinase is expressed in the form of two separate
polypeptides, each fused to a different rapamycin-
binding protein (FKBP12 and FRB). The addition of
rapamycin induces heterodimerization of these two
components and restores recombinase activity
(Jullien et al. 2003; Jullien et al. 2007).
SSR systems have a high versatility and allow
multiple applications, such as removal, inversion
or integration of DNA sequences (Bouabe and
Okkenhaug, 2013). In our experience, the most
reliable application in T. gondii is the GeneSwap
strategy (Andenmatten et al. 2013). Here a vector
including the cDNA of the GOI flanked by loxP sites
and under control of the endogenous promoter is
used. In case of intron-less GOIs it might be worth
using a synthetic gene to avoid homologous recom-
bination within the cDNA. Downstream of the
second loxP site a reporter gene, YFP, was placed
followed by the selectable marker and the 3′-UTR of
the GOI. This cassette is introduced into the locus of
the GOI by double homologous recombination.
Consequently, induction of DiCre results in YFP-
positive parasites that have completely lost the GOI.
This approach has been successfully used to generate
parasites devoid of genes, such as myoA, mic2, act1
(Andenmatten et al. 2013), ama1 (Bargieri et al.
2013), dhhc7 (Frenal et al. 2013), mlc1, myoA/B/C,
gap40, gap45, gap50 (Egarter et al. 2014) and others.
Also, in P. falciparum the induction of DiCre-
recombinase results in nearly the whole parasite
population excising the floxed DNA sequence
(Collins et al. 2013).
While generation of conditional mutants with the
DiCre system promises a very high success rate
(>90%), there are some advantages and disadvantages
that need to be considered. The introduced
modifications are less likely to interfere with gene
function, since the GOI will be regulated by its own
endogenous promoter. Upon excision of the GOI, it
is possible to obtain parasites without any residual
expression. However, the regulation is irreversible
and one has to keep inmind that induction results in a
mixed population where 20–96% of the parasites
display the desired knockout phenotype. While the
GeneSwap strategy allows easy identification of
knockouts due to expression of YFP, other ap-
proaches, such as proteomics, might be hindered by
contamination with non-induced parasites. However,
contamination with non-induced parasites could be
overcome or minimized by enriching for YFP-
positive parasites using sorting methods such as
FACS. Despite a short induction of DiCre (<4 h)
being sufficient to trigger excision of the GOI, the
kinetic of down-regulation can be very slow depend-
ing on the stability of the protein, similar to the Tet-
transactivation system.
DIRECT COMPARISON OF TATi , DDFKBP AND
DICRE
To date the function of only a few genes have been
analysed using all three technologies. Strikingly, the
observed phenotypes have been different depending
upon which technique was used to disrupt the same
gene. This has affected the interpretation of data and
conclusions, for example the work describing the
role of the glideosome in host cell invasion. The
glideosome is a macromolecular complex involved in
gliding motility which is anchored to the plasma
membrane (PM) and the inner membrane complex
(IMC) (Frenal et al. 2010). It is described as essential
machinery for host-cell invasion and egress in api-
complexan parasites of which myosin A (MyoA) was
thought to play a key role.
A phenotypic characterization of MyoA was
performed using the technologies described above:
modification at a genomic level by removal of the
gene using DiCre (Fig. 1A–C) (Andenmatten et al.
2013; Egarter et al. 2014); at a transcriptional level,
using the Tet-transactivator system (Fig. 1D and E)
(Meissner et al. 2002); and at a protein level, using the
ddFKBP-system to over-express the MyoA-tail
(Fig. 1F and G) (Agop-Nersesian et al. 2009).
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Reduction in MyoA expression levels using the
Tet-transactivator system resulted in significant re-
duction of gliding motility and host cell invasion,
leading to the conclusion that MyoA is the essential
motor protein powering these processes (Meissner
et al. 2002). Residual expression of MyoA was
Fig. 1. Comparative analysis of inducible knockout systems and their applications for the motor protein MyoA (adapted
from Meissner et al. 2002; Herm-Gotz et al. 2007; Andenmatten et al. 2013). Manipulation at the genomic level using
the DiCre system (A)/(B). Replacement of endogenous MyoA locus with a cDNA copy (A). Upon rapamycin induction,
MyoA is irreversibly removed by excision of the MyoA cDNA (B)/(C). Transcriptional manipulation using the
Tet-inducible system, transcription is inhibited by addition of anhydrotetracycline (ATc) preventing transactivator
binding to the promoter region and therefore silencing transcription (D). Myc tagged MyoA expression was shown to be
disrupted by immunofluorescence assay (IFA) (E). Manipulation of proteins containing the DD domain, addition of
Shld-1 allows stability and over-expression (F). Myc tagged MyoA degradation shown by IFA (G).
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interpreted as the cause for the ‘minimal levels of
invasion’ detected with this technology.
Intriguingly, over-expression of a ddFKBP-
myoA-tail construct not only showed reduced in-
vasion efficiency but also a block in intracellular
replication. The over-expressed DD-tagged MyoA
may have interacted with critical factors required
during IMC biogenesis and acted as a dominant-
negative protein. This effect was interpreted asMyoA
having a second function during the asexual life cycle
that cannot be resolved by reduction of expression
levels (Agop-Nersesian et al. 2009). While it will
be very interesting to identify the putative interaction
partners of ddFKBP-myoA-tail, this example dem-
onstrates that great care has to be taken when
analysing dominant negative mutants.
Therefore, while the systems provided consistent
data on the function of MyoA, using the DiCre
system allowed the isolation of a viable myoA null
mutant which shed further light on its essentiality,
and calls for a more detailed analysis of the mechan-
isms involved in host cell invasion and for IMC
biogenesis (Andenmatten et al. 2013; Egarter et al.
2014).
The role of the rhomboid protease ROM4 in the
cleavage of the micronemal proteins MIC2 and
AMA1 was also studied using several different gen-
etic systems. Initially down-regulation of ROM4 was
established by using the Tet-transactivator system
(Buguliskis et al. 2010) and resulted in reduced
invasion. Surprisingly, expression of a dominant
negative version of ROM4 using the ddFKBP
system led to a block of intracellular replication.
Intriguingly, simultaneous over-expression of the
AMA1-tail domain (the presumed cleavage product
of ROM4) fused to ddFKBP, was sufficient to release
this block and it was concluded that the ROM4-
AMA1 processing step is required to trigger a signal
for intracellular replication of T. gondii (Santos et al.
2011).
Null mutants for rom4, ama1 and mic2 were
recently generated using the DiCre system
(Andenmatten et al. 2013; Bargieri et al. 2013;
Rugarabamu et al. 2013), surprisingly, showing
no intracellular replication defects. A possible ex-
planation for this discrepancy is a non-specific,
pleiotropic effect caused by the expression of the
dominant negative forms fused to ddFKBP. This
explanation is favoured by the observation that
neither ROM4 nor AMA1 mutants showed repli-
cation defects. The ability to isolate viable null
mutants for these genes supports the notion that
host cell invasion is more complex than initially
perceived.
In summary, discrepancies in phenotypic conse-
quences can be observed especially between mutants
generated by ddFKBP and Tet/DiCre. Therefore, it
is our recommendation to attempt a characterization
using over-expression and knockout/knockdown
approaches to identify potential downstream effects
or, in the worst case, artefacts.
RECOMBINATION-MEDIATED GENETIC
ENGINEERING
Classical characterization of gene function using
parasite lines carrying mutations in a single GOI
are time consuming and only offer limited infor-
mation. Improved technologies moving towards
high-throughput approaches to study gene function
are necessary to allow for progression in the under-
standing of gene regulation in apicomplexan para-
sites. Recombineering is an efficient method for
DNA engineering using homologous recombination
in E. coli. This technique allows modification of
DNA at any chosen position based on short regions of
sequence homology. Transient expression of the
recombinase complex and proofreading activity of
lambda red operon allows controlled Recombineer-
ing to be initiated (Wang et al. 2006). Recently, it was
used to modify the apicoplast membrane localized
phosphate translocator (APT) using COSMID li-
braries in T. gondii (Brooks et al. 2010). The Re-
combineering method has been adapted to generate
P. berghei vectors for transfection in high throughput
(Pfander et al. 2011). Currently, the Sanger Institute
(Genome Campus, Hinxton, UK) maintain the
PlasmoGem database (http://plasmogem.sanger.ac.
uk) therefore gene knockout and tagged gene vectors
produced using Recombineering and GateWay tech-
nologies are annotated and can be obtained for
downstream functional analysis.
It will be important to establish a similar
technology and distribution system for T. gondii
large-scale genome manipulation. A combination of
Recombineering with the current toolbox described
above should be possible to fulfil this goal.
GENOME EDITING IN APICOMPLEXAN PARASITES
One alternative to Recombineering could be employ-
ment of genome editing tools, such as artificially
developed zinc finger nucleases (ZFNs) (Kim et al.
1996; Nain et al. 2010), transcription activator-like
effector (TALE) nucleases from Xanthomonas spp.
(Boch et al. 2009; Kay and Bonas, 2009; Pan et al.
2013) or clustered regularly interspaced short palin-
dromic repeat (CRISPR) cas9 from Streptococcus
pyogenes (Mali et al. 2013; Sampson and Weiss,
2014). Each ZF domain consists of an array of protein
fingers stabilized by zinc ion that recognize a specific
triplet of DNA sequence (Fig. 2A). TALE mono-
mers directly bind to DNA via a central domain of
tandem repeats (Fig. 2B). The type II CRISPR/Cas
system is being used in genetic manipulation of
eukaryotic cells, allowing for the introduction of
double-strand breaks (DBS) after addition of a small
guide RNA into target genomes (Ran et al. 2013)
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(Fig. 2C). The DSB produced by any of these
nuclease-based technologies can lead to non-hom-
ologous end joining (NHEJ) repair or, in case of the
presence of a donor vector, to homology-directed
repair (HDR) (Fig. 2D). ZF and TALE monomer
construction requires specialist expertise as the
probability of mismatch sequences causing off-target
mutagenesis is high. The costs for generating the ZF
or TALE libraries are relatively high whereas
CRISPR/Cas9 technology offers a cheap alternative.
The main advantage of using nucleases for genome
editing is the ability to directly engineer the genome
of the organism being studied without the necessity
of prior preparation of constructs with GOI DNA
using recombinant DNA technology. Given the
possibility for employing these new technologies for
the manipulation of a wide range of organisms,
adaptation of these technologies to apicomplexan
gene studies would allow for greater scale of
manipulation of the genome and efforts are being
made to establish these new technologies into the
current repertoire of molecular tools for the manipu-
lation of T. gondii and Plasmodium spp. parasites.
OUTLOOK
The toolbox for genetic engineering discussed here
demonstrates that each technology has its limitations
andoptimally synergistic technologies (such asknock-
down and dominant negative expression) should be
used to investigate gene function. However, the
examples discussed above are not the only technolo-
gies employed to manipulate the genome in eukar-
yotic cells and several alternatives exist thatwe did not
include in this review, such as the use of ribozymes
(Agop-Nersesian et al. 2008; Prommana et al. 2013)
or auxin-based degron systems (Jebiwott et al. 2013).
One aim for the future is the establishment of
technologies that will allow the generation of mutants
on a large scale. This likely will require the com-
bination of inducible genetic tools, such as the Tet-
system or DiCre with CRISPR or Recombineering
for the comprehensive analysis of essential genes.
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Fig. 2. Nuclease-mediated genome editing (adapted from Pan et al. 2013; Sampson and Weiss, 2014). Each monomer of
zinc finger nuclease (ZFN) recognizes 3 bp DNA (A). Monomers of the transcription Activator-Like Effectors Nucleases
(TALENs) system bind to a specific nucleotide sequence (B). Cas9 nuclease forms a complex with the chimera sgRNA,
comprising a crRNA and a tracrRNA. This RNA guides the nuclease to the target locus (C). These nucleases will
induce a double strand brake (DSB) in the gene that will be followed by non-homologous end joining (NHEJ) repair if
no donor vector is supplied. If a plasmid with homologous regions is added the introduction of foreign DNA can be
achieved (D).
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